[
  {
    "ts": null,
    "headline": "Can Keytruda Sustain Merck's Growth Through the Rest of 2025?",
    "summary": "MRK banks on Keytruda's soaring sales and new oncology strategies to fuel 2025 growth, even as competition and patent loss loom.",
    "url": "https://finnhub.io/api/news?id=6b096a67d960612b50b9b6ad26359fd811ddbbb0b60b3c285dafa5330af78ea9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755608760,
      "headline": "Can Keytruda Sustain Merck's Growth Through the Rest of 2025?",
      "id": 136430193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "MRK banks on Keytruda's soaring sales and new oncology strategies to fuel 2025 growth, even as competition and patent loss loom.",
      "url": "https://finnhub.io/api/news?id=6b096a67d960612b50b9b6ad26359fd811ddbbb0b60b3c285dafa5330af78ea9"
    }
  }
]